Attitudes toward colorectal cancer screening tests

OBJECTIVE: To examine patient and physician preferences in regard to 5 colorectal cancer screening alternatives endorsed by a 1997 expert panel, determine the impact of patient and physician values regarding certain test features on screening preference, and assess physicians’ perceptions of patients’ values.DESIGN: Cross-sectional survey.SETTING: A general internal medicine practice at an academic medical center in 1998.PARTICIPANTS: Patients (N=217; 76% response rate) and physicians (N=39; 87% response rate) at the study setting.MEASUREMENTS AND MAIN RESULTS: Patients preferred fecal occult blood testing (43%) or colonoscopy (40%). In patients for whom accuracy was the most important test feature, colonoscopy (62%) was the preferred screening method. Patients for whom invasive test features were more important preferred fecal occult blood testing (76%; P<.001). Patients and physicians were similar in their values regarding the various test features. However, there was a significant difference between physicians’ perceptions of which test features were important to patients compared with the patients’ actual responses (P<.001). The largest discrepancy was for accuracy (patient actual 54% vs physician opinion 15%) and discomfort (patient actual 15% vs physician opinion 64%).CONCLUSIONS: Patients have distinct preferences for colorectal cancer screening tests that are associated with the importance placed on certain test features. Physicians incorrectly perceive those factors that are important to patients. Physicians should incorporate patient values in regard to certain test features when discussing colorectal cancer screening with their patients and when eliciting their screening preferences.

[1]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[2]  C. Mulrow,et al.  Colorectal cancer screening: clinical guidelines and rationale. , 1997, Gastroenterology.

[3]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[4]  R Wender,et al.  American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection , 2001, CA: a cancer journal for clinicians.

[5]  S. Vernon,et al.  Participation in colorectal cancer screening: a review. , 1997, Journal of the National Cancer Institute.

[6]  B E Storer,et al.  Screening sigmoidoscopy and colorectal cancer mortality. , 1992, Journal of the National Cancer Institute.

[7]  T. Church,et al.  Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.

[8]  B. Flehinger,et al.  Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. , 1993, Journal of the National Cancer Institute.

[9]  A. Sonnenberg,et al.  Prevention of Colorectal Cancer by Flexible Endoscopy and Polypectomy: A Case-Control Study of 32 702 Veterans , 1995, Annals of Internal Medicine.

[10]  L M Schuman,et al.  The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.

[11]  G. Friedman,et al.  A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. , 1992, The New England journal of medicine.

[12]  J. Cuzick,et al.  Prevention of colorectal cancer by once-only sigmoidoscopy , 1993, The Lancet.

[13]  A. Zauber,et al.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .

[14]  Graham A. Colditz,et al.  Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.

[15]  P Politser,et al.  How decisions are reached: physician and patient. , 1982, Annals of internal medicine.

[16]  Michael Pignone,et al.  Patient preferences for colon cancer screening , 1999, Journal of general internal medicine.

[17]  J. Kirscht,et al.  Understanding and improving patient compliance. , 1984, Annals of internal medicine.

[18]  J G Dolan,et al.  Are Patients Capable of Using the Analytic Hierarchy Process and Willing to Use It to Help Make Clinical Decisions? , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[19]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[20]  A. Sonnenberg,et al.  Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer , 2000, Annals of Internal Medicine.

[21]  S. Quinn,et al.  African Americans' views on research and the Tuskegee Syphilis Study. , 2001, Social science & medicine.

[22]  H. Brody,et al.  Physician Recommendations and Patient Autonomy: Finding a Balance between Physician Power and Patient Choice , 1996, Annals of Internal Medicine.

[23]  David Haber,et al.  Guide to clinical preventive services: a challenge to physician resourcefulness , 1993 .

[24]  Stephan D. Fihn,et al.  How Doctors and Patients Discuss Routine Clinical Decisions: Informed Decision Making in the Outpatient Setting , 1997 .

[25]  T G Ganiats,et al.  Patient preferences for colorectal cancer screening. , 1996, The Journal of family practice.

[26]  D A Redelmeier,et al.  Understanding patients' decisions. Cognitive and emotional perspectives. , 1993, JAMA.

[27]  D. Brody,et al.  The patient's role in clinical decision-making. , 1980, Annals of internal medicine.

[28]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[29]  J. Weissfeld,et al.  Sigmoidoscopy use among primary care physicians. , 1995, Preventive medicine.

[30]  L. Kinsinger,et al.  Videotape-Based Decision Aid for Colon Cancer Screening , 2000, Annals of Internal Medicine.